A new study from University Hospitals Connor Whole Health reports that an insurance-supported integrative oncology program resulted in clinically meaningful improvements in cancer-related symptoms like pain, stress, anxiety, depression, nausea, and fatigue. The findings highlight a scalable model with potential for delivering future integrative therapies within routine oncology care. The findings from this study were recently published in JCO Oncology Practice.
The study, entitled "Implementation and Patient-Reported Outcomes of an Insurance-Supported Integrative Oncology Symptom Management Program," evaluated the first 16 months of the Connor Whole Health Integrative Oncology (CWHIO) Symptom Management Clinic. The clinic delivered 1,924 integrative oncology treatments to 291 patients between June 2023 and September 2024, using a hybrid model that combined both insurance-billed physician visits and massage visits with low-cost group acupuncture sessions and additional philanthropic support for non-billable services.
Integrative oncology bridges the best of conventional cancer treatment with evidence-based supportive therapies like acupuncture. This program demonstrates how acupuncture can help address symptom burden and improve quality of life when incorporated into comprehensive cancer care."
Jacob Wolf, ND, LAc, Dipl. OM, naturopathic doctor and licensed acupuncturist, UH Connor Whole Health
Dr. Wolf currently serves as Medical Director of Acupuncture at UH Connor Whole Health and is board-certified in acupuncture, Asian herbal medicine, and lifestyle medicine.
The study demonstrated significant clinical benefits for patients, with single treatments leading to meaningful reductions in moderate-to-severe symptoms, including pain (–2.08), stress (–2.70), anxiety (–2.28), depression (–2.54), nausea (–3.61), and fatigue (–1.42). Additionally, patient satisfaction was exceptionally high throughout the program, with 87.1% strongly agreeing they were satisfied with the services, 85.5% strongly agreeing they would refer others, and 82.3% strongly agreeing the services supported effective symptom management. There was an upward trend in demand for care throughout; with weekly visit volumes frequently exceeding 40 and ultimately peaking at 57 encounters per week following the introduction of group acupuncture and individualized reiki.
The CWHIO clinic was led by an integrative oncologist and embedded within the University Hospitals Seidman Cancer Center network. Treatment plans aligned with American Society of Clinical Oncology and National Comprehensive Cancer Network guidelines for integrative therapies, including acupuncture and massage for pain, anxiety, depression, and fatigue.
"A whole health approach to cancer care – one that integrates evidence-based lifestyle and supportive therapies – is well supported by the scientific literature. This study highlights strong patient interest in these services while underscoring persistent system-level barriers that continue to limit access," said Kristi Artz, MD, MS, FACLM, CCMS, Vice President of UH Connor Whole Health and Sara H. Connor Chair in Integrative Health.
This hybrid clinic model addresses barriers to accessing integrative oncology access such as limited insurance reimbursement. Initial physician consults and massage therapy are billed through insurance, while group acupuncture is offered at a low self-pay rate of $36.85, which is below national averages. Most U.S. integrative oncology programs rely heavily on out-of-pocket payments, creating many disparities for patients. By embedding integrative services within oncology workflows and prioritizing insurance-billable care, the CWHIO model aims to reduce financial barriers for patients and expand reach throughout the hospital system.
The research was supported by the Elisabeth Severance Prentiss Foundation.
Source:
Journal reference:
Srivastava, M., et al. (2026). Implementation and Patient-Reported Outcomes of an Insurance-Supported Integrative Oncology Symptom Management Program. JCO Oncology Practice. DOI: 10.1200/OP-26-00274. https://ascopubs.org/doi/10.1200/OP-26-00274
Facts Only
* The Connor Whole Health Integrative Oncology Symptom Management Clinic evaluated 16 months of service.
* The clinic delivered 1,924 integrative oncology treatments to 291 patients between June 2023 and September 2024.
* Treatments included insurance-billed physician visits, massage visits, low-cost group acupuncture sessions, and philanthropic support for non-billable services.
* Single treatments led to reductions in moderate-to-severe symptoms: pain (–2.08), stress (–2.70), anxiety (–2.28), depression (–2.54), nausea (–3.61), and fatigue (–1.42).
* Patient satisfaction was high: 87.1% strongly agreed with satisfaction, 85.5% agreed they would refer others, and 82.3% agreed services supported effective symptom management.
* Visit volumes increased, peaking at 57 encounters per week following the introduction of group acupuncture and reiki.
* Treatment plans adhered to American Society of Clinical Oncology and National Comprehensive Cancer Network guidelines for integrative therapies.
* Group acupuncture was offered at a low self-pay rate of $36.85.
Executive Summary
An insurance-supported integrative oncology program at University Hospitals Connor Whole Health demonstrated clinically meaningful improvements in various cancer-related symptoms among patients over a 16-month period. The program utilized a hybrid model combining insurance-billed physician and massage visits with low-cost group acupuncture sessions and philanthropic support for non-billable services. Patients experienced significant symptom reductions, including notable decreases in pain, stress, anxiety, depression, nausea, and fatigue following single treatments. Patient satisfaction levels were high, with most strongly agreeing with the services and their effectiveness. The clinic was embedded within the University Hospitals Seidman Cancer Center network and aligned treatment plans with established oncology guidelines for integrative therapies.
The program demonstrated that integrating evidence-based supportive therapies like acupuncture can help manage symptom burden and improve quality of life within comprehensive cancer care. The hybrid financial model addresses access barriers by incorporating insurance billing while offering low-cost options, such as group acupuncture at a reduced rate compared to national averages, aiming to mitigate the disparities often found in traditional oncology care access.
Full Take
The structure of the intervention, utilizing an insurance-supported hybrid model, directly addresses a significant systemic barrier: financial access to integrative oncology care. The finding that symptom management via acupuncture yields measurable clinical benefits suggests that these therapies are not merely adjunctive but possess genuine efficacy in mitigating the burden of cancer symptoms, aligning well with the established concept that quality of life impacts survivorship outcomes. The observed patient satisfaction metrics, particularly high rates of referral and agreement on symptom management support, indicate a strong alignment between patient experience and therapeutic goals.
The tension exists between demonstrating clinical efficacy within an integrated setting and navigating the persistent "system-level barriers" mentioned by leadership. While the model successfully reduces financial access hurdles through strategic billing, the scalability hinges on maintaining this complex hybrid structure within existing oncology workflows. The upward trend in demand, driven by modalities like group acupuncture, suggests a market pull that could force systemic changes beyond simple reimbursement adjustments. The core implication is that embedding supportive therapies into conventional care pathways can normalize and legitimize integrative approaches, shifting the paradigm from optional add-ons to integrated standards of care.
Bridge questions: What are the long-term financial sustainability models for maintaining the low-cost group acupuncture structure as demand fluctuates? How can this successful hybrid model be systematically replicated across diverse oncology networks without reliance on a single specialized clinic setup? What institutional mechanisms need to evolve to move the demonstrated clinical utility into standard protocols, rather than remaining an evidence-based program?
Sentinel — Human
The text appears to be a synthesized journalistic report based on a specific research study, demonstrating typical patterns of human-authored reporting rather than purely generative output.